Inspire Investing, LLC Ligand Pharmaceuticals Inc Transaction History

Inspire Investing, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$74.52 - $117.06 $513,517 - $806,660	-6,891 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$94.99 - $151.56 $654,576 - $1.04 Million	6,891 New	6,891 $775,000
Q1 2021 Apr 30, 2021	SELL	$99.52 - $215.83 $210,385 - $456,264	-2,114 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $170,282 - $224,189	2,114 New	2,114 $210,000
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $161,476 - $228,476	-1,803 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$68.28 - $123.65 $66,299 - $120,064	-971 Reduced 35.0%	1,803 $202,000
Q1 2020 May 08, 2020	BUY	$63.37 - $107.88 $175,788 - $299,259	2,774 New	2,774 $202,000
Q1 2018 Apr 13, 2018	SELL	$138.63 - $182.62 $58,640 - $77,248	-423 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$128.36 - $147.04 $54,296 - $62,197	423	423 $58,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.